About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Genetico
Gemabank
Histograft
Nextgen
Genotarget
Biotechnology Developments
Betuvax
Reprobank
Vitacel
10.06.2024
Press releases
Preclinical Studies of a Russian Drug for the Treatment of Muscular Dystrophy Completed
07.06.2024
News
Artgen Biotech at the SPIEF: The ‘Advanced Pharmaceutics of Russia’ Session
22.05.2024
Press releases
RBT at the Sirius.Biotech summit
14.05.2024
News
According to Artgen Biotech, the number of patients with interstitial cystitis will double in 10 years
07.05.2024
News
Gemabank Board of Directors recommended dividends
27.04.2024
News
Artgen Biotech Board of Directors recommended dividends
26.04.2024
Press releases
Artgen Biotech operating results for 2023 according to IFR
1
2
3
4
5
6
…
14
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
